GlassScriptPhysician profile
Justin L Hart
NPI 1669491296
$1,082.93
in general payments reported to CMS, 2019-2025
7 companies · $87.65 in 2025
The $87.65 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.22 · 2020: $100 · 2021: $92.27 · 2022: $179 · 2023: $506 · 2024: $89.50 · 2025: $87.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $682.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $474.51 | 2019-2025 | Hydrus Microstent, Total30, Precision 1 |
| Bausch & Lomb Americas INC. | $307.29 | 2022-2025 | Infuse, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $109.88 | 2020-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $91.73 | 2023 | Lipiflow System Activator (Disposable) |
| Coopervision INC. | $58.74 | 2022-2025 | Clariti Contact Lens, Misight Contact Lens |
| Oyster Point Pharma, INC. | $20.66 | 2024 | Ryzumvi, Tyrvaya |
| Sun Pharmaceutical Industries INC. | $20.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Hart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.